Optimi Health (OPTI.CN) Stock Price

Optimi Health Price

OTC·CLOSED
5.85
​
Market closed

Over the last 3 years Optimi Health grew revenue by 74.1% annually, reaching 426,301.00 CAD. For Optimi Health, the net margin of -870.8% is up versus -9,106.9% a few years ago.

Optimi Health stock price

Access this data via the Eulerpool API

Optimi Health business model & stock analysis

Optimi Health Corp. engages in the development, cultivation, extraction, processing, and distribution of functional mushrooms. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-02-25. The firm is a drug manufacturer and formulator licensed by Health Canada to produce and supply psychedelic substances, such as 3,4-Methylenedioxymethamphetamine (MDMA) and natural, Good Manufacturing Practice (GMP)-grade psilocybin, psilocin, and other psychedelic substances, some being synthetically formulated, as well as functional mushrooms that focus on domestic and international health and wellness markets. The firm owns approximately 20,000 technologically advanced manufacturing, cultivation and analytical facilities. The company also invests in in providing the supply of synthetic and natural psychedelics to the international market. The firm operates as a supplier of drug and nutraceutical products serving health food distributors, and drug developers and patients regulated by Health Canada.

Frequently asked questions about Optimi Health

Converted at the current exchange rate, the Optimi Health share trades at 3.66 EUR (5.85 CAD).

The Optimi Health share (OPTI.CN) is listed on 5 stock exchanges, including: Frankfurt (8BN.F), München (8BN.MU), Düsseldorf (8BN.DU), Hamburg (8BN.HM).

The expected revenue of Optimi Health is 665,740.00 CAD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Optimi Health is -137.43 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Optimi Health is currently -0.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Optimi Health stock.

The price-to-sales ratio (P/S) of Optimi Health is currently 0.94. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Optimi Health stock.

The Eulerpool Quality Score for Optimi Health is 3/10.

The ISIN of Optimi Health is CA68405H1001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Optimi Health is A2QQEL. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Optimi Health is OPTI.CN. The ticker symbol is used to trade Optimi Health shares on the stock exchange.

Fair ValueTerminal
6.03 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue per Employee
47,366.78 CAD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Feb 25, 2021
ISIN
CA68405H1001
Cusip
68405H100
Market capitalization
566.16 M CADSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-0.00
P/Ee 2027
-0.01
P/Ee 2028
—
P/S
P/Se
0.94
EV/EBIT
—
P/B Ratio
86.17
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-56.49 %
Last updated Oct 10, 2026, 8:25 PM

Optimi Health Peer Group

Optimi Health Ticker

DÜSSELDORF · 8BN.DUFRANKFURT · 8BN.FHAMBURG · 8BN.HMMUNICH · 8BN.MUOTC · OPTHF

Optimi Health FIGI

OPTI:CN · BBG00ZF25693OPTI:CF · BBG00ZF256H4OPTI:TG · BBG00ZF256R3OPTI:TW · BBG00ZF256T1OPTI:DG · BBG00ZF25700OPTI:QF · BBG00ZF25719OPTI:QH · BBG00ZF25728OPTI:TO · BBG00ZF25755OPTI:QG · BBG00ZF257918BN:GR · BBG00ZLHFNM08BN:GF · BBG00ZLHFNN98BN:GD · BBG00ZLHFNP7